These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lateralization of the crossed cerebellar diaschisis-associated metabolic connectivities in cortico-ponto-cerebellar and cortico-rubral pathways. Zhu Y; Ruan G; Cheng Z; Zou S; Zhu X Neuroimage; 2022 Oct; 260():119487. PubMed ID: 35850160 [TBL] [Abstract][Full Text] [Related]
5. Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Kajimoto K; Oku N; Kimura Y; Kato H; Tanaka MR; Kanai Y; Kitagawa K; Maruno M; Yoshimine T; Hori M; Hatazawa J Ann Nucl Med; 2007 Feb; 21(2):109-13. PubMed ID: 17424977 [TBL] [Abstract][Full Text] [Related]
6. FDG PET/MRI for Visual Detection of Crossed Cerebellar Diaschisis in Patients With Dementia. Franceschi AM; Clifton MA; Naser-Tavakolian K; Ahmed O; Bangiyev L; Clouston S; Franceschi D AJR Am J Roentgenol; 2021 Jan; 216(1):165-171. PubMed ID: 33170738 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis. Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568 [TBL] [Abstract][Full Text] [Related]
8. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077 [TBL] [Abstract][Full Text] [Related]
9. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression. Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D; PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116 [TBL] [Abstract][Full Text] [Related]
10. The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease. Adriaanse SM; Wink AM; Tijms BM; Ossenkoppele R; Verfaillie SC; Lammertsma AA; Boellaard R; Scheltens P; van Berckel BN; Barkhof F Brain Connect; 2016 Feb; 6(1):1-8. PubMed ID: 26414628 [TBL] [Abstract][Full Text] [Related]
11. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease. Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714 [TBL] [Abstract][Full Text] [Related]
12. Tracer-specific reference tissues selection improves detection of Li Y; Ng YL; Paranjpe MD; Ge Q; Gu F; Li P; Yan S; Lu J; Wang X; Zhou Y; Hum Brain Mapp; 2022 May; 43(7):2121-2133. PubMed ID: 35165964 [TBL] [Abstract][Full Text] [Related]
14. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. Ossenkoppele R; Rabinovici GD; Smith R; Cho H; Schöll M; Strandberg O; Palmqvist S; Mattsson N; Janelidze S; Santillo A; Ohlsson T; Jögi J; Tsai R; La Joie R; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; Choi JY; Ryu YH; Lyoo CH; Hansson O JAMA; 2018 Sep; 320(11):1151-1162. PubMed ID: 30326496 [TBL] [Abstract][Full Text] [Related]
15. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052 [TBL] [Abstract][Full Text] [Related]
16. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Ben Bouallègue F; Mariano-Goulart D; Payoux P; Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967 [TBL] [Abstract][Full Text] [Related]
17. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein. Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898 [TBL] [Abstract][Full Text] [Related]
18. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study. Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367 [TBL] [Abstract][Full Text] [Related]
19. Early-phase 18F-AV-45 PET Imaging can Detect Crossed Cerebellar Diaschisis Following Carotid Artery Stenosis and Cerebral Hypoperfusion. Lee TH; Huang KL; Chang TY; Ho MY; Wey SP; Hsieh CJ; Yen TC; Lin KJ; Hsiao IT Curr Neurovasc Res; 2017; 14(3):258-265. PubMed ID: 28637413 [TBL] [Abstract][Full Text] [Related]
20. Brain Kucharczak F; Suau M; Strauss O; Ben Bouallègue F; Mariano-Goulart D Ann Nucl Med; 2020 Aug; 34(8):565-574. PubMed ID: 32578152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]